pre‑emptive genomic testing
30% Isn’t What You Were Told About Longevity Science
Retirees who undergo pre-emptive genomic testing can lower age-related disease risk by up to 30% and save tens of thousands of dollars in healthcare costs over a decade. The science behind these claims is emerging, but the data reveal a nuanced picture that challenges common marketing hype. In 2025, a